1. There is a maximum of 4 image uploads allowed. The only accepted file formats are JPG, JPEG, PNG, and GIF. There are four sections: Background, Methods Results, and Conclusions. Each section allows a total number of characters of 2500 (including spaces).

    2. Abstracts that have been previously published or presented will NOT be eligible for presentation at SCAI. If your abstract is accepted for presentation at another meeting or published prior to the SCAI 2014 Scientific Sessions you must notify SCAI immediately to withdraw your abstract.

    3. Case Studies will NOT be accepted or considered for presentation at the SCAI 2014 Scientific Sessions.

    4. Abstract submissions must fit into one of the following categories:

      • Acute Coronary Syndromes, Myocardial Infarction, Thrombectomy and
        Vulnerable Plaque
      • Adult Congenital
      • Angiogenesis, Myogenesis, Cell Therapy and Gene Therapy
      • Complex PCI, Restenosis, Left Main & Multi-Vessel Intervention
      • Contrast Agents
      • Endovascular and Peripheral Interventions (Including Neurovascular and
      • Imaging: CT, MR and Non-Invasive Imaging
      • Intravascular Imaging (IVUS)/Physiology
      • Left Main & Multi-Vessel Intervention
      • Miscellaneous
      • Pediatric
      • Pharmacotherapy
      • Quality Improvement
      • Stents (including DES)
      • Valvular Interventions and Structural Heart Disease
      • Vascular Access and Arterial Closure Devices

    5. All revisions must be made by the abstract submission deadline.

    6. Requests to withdraw an abstract must be submitted in writing to meetings@scai.org by February 5, 2014.

    7. Abstract grading is blind. Please do not include author or institution names in the body of your abstract.

    8. Guidelines for presentations will be provided to authors of accepted abstracts upon notification of acceptance.

    9. Abstract acceptance notifications will be e-mailed to the addresses provided for the submitting and presenting authors in late February.

    10. Media coverage of abstracts and clinical trials presented at SCAI 2014 Scientific Sessions is prohibited until the start time of the presentation or the beginning of the session containing the research. The embargo on poster presentations lifts when the poster session containing the poster opens for viewing. Questions regarding SCAI's embargo policy should be directed to Kathy Boyd David at kbdavid@scai.org.

    View the SCAI 2014 Abstract and Late-Breaking Clinical Trial Submission Rules


    Please contact SCAI Meetings Manager Rachel Pham at RPham@scai.org or (202) 741-9812.

  • Acknowledgements

    SCAI gratefully acknowledges the following companies for their generous support of the SCAI 2014 Scientific Sessions through educational grants while taking sole responsibility for all content developed and disseminated through this event.

    Platinum Sponsors

    • Abbott Vascular
    • Boston Scientific

    Silver Sponsors

    • AstraZeneca
    • Medtronic

    Bronze Sponsors

    • Cook Medical
    • Cordis, a Johnson & Johnson Company
    • Covidien
    • Gilead Sciences
    • St. Jude Medical
    • Terumo Interventional Systems

    SCAI also appreciates the educational grant support provided by Spectranetics.